Mativ Holdings, Inc. · NYSE:MATV
Mativ — Q2 2025 Earnings Presentation
11 slides from Mativ's earnings presentation, Aug 7, 2025
Slide 1: Mativ Second Quarter 2025 Earnings Release Presentation
Mativ Second Quarter 2025 Earnings Release Presentation August 2025
Slide 2: Forward Looking Statements, Non-GAAP Disclosure, & Definitions
Forward Looking Statements, Non-GAAP Disclosure, & Definitions This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws that are subject to the safe harbor created by such laws and other le
Slide 3: Q2 Consolidated Results
Q2 Consolidated Results • Sales were up 2% organically year-over-year, driven by organic volume improvements in SAS and ($ millions, except EPS) Q2 FY25 Q2 FY24 favorable currency across the company Sales $525.4 $523.8 Organic Sales $525.4 $512.1 • GAAP loss was $9.5 million, GAAP EPS was $(0.18) Or
Slide 4: Q2 Consolidated Results Variances
Q2 Consolidated Results Variances Net Sales Adj. EBITDA $7.3 $525.4 $523.8 $1.8 $66.6 $0.7 $67.2 $(2.0) $(5.4) $(0.3) Q2 FY24 Volume/Mix Volume/Mix Price Currency Currency Q2 FY25 Q2 FY25 Q2 FY24 Volume/Mix Volume/Mix Price/Cost Mfg. Costs Mfg. Costs & Q2 FY25 Q2 FY24 Price/Cost & Other Other Q2 FY2
Slide 5: Q2 Segment Results
Q2 Segment Results ($ millions) Q2 FY25 Q2 FY24 • FAM Sales reflecting lower selling prices, lower volume/mix, partially Sales $204.4 $206.4 offset by favorable currency translation % versus: -1% • SAS Sales were up 5% on organic basis as higher organic volume, FAM GAAP Operating Profit $22.6 $25.2
Slide 6: 2025 Key Priorities To Drive Improved Performance
2025 Key Priorities To Drive Improved Performance Driving De-Lever through Margin and Cash Conduct Enhanced Commercial Execution Flow Improvement Strategic Portfolio Review • Leverage successful SAS go-to-market • Announced pricing actions effective in • Strategic review of assets and business lines
Slide 7: 2025 Full Year Considerations
2025 Full Year Considerations • Additional cost reductions of $15-20 million • Depreciation, amortization and stock-based comp to be around $100 million • Interest expense to be around $75 million plus another $9 million in fees for our A/R facility • Capital expenditures of around $40 million • One
Slide 8: Appendix
Appendix ANNSAANS AANANAANS AANANAN TVS
Slide 9: Non-GAAP Reconciliation: Segment Reporting
Non-GAAP Reconciliation: Segment Reporting 9
Slide 10: Non-GAAP Reconciliation: Segment Reporting (cont.)
Non-GAAP Reconciliation: Segment Reporting (cont.) 10
Slide 11: Non-GAAP Reconciliation: Consolidated Reported Results
Non-GAAP Reconciliation: Consolidated Reported Results 11